Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis ; volume:23 ; number:1 ; day:23 ; month:7 ; year:2021 ; pages:1-10 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (23.7.2021), 1-10, 12.2021
- Creator
-
Iwamoto, Naoki
Sato, Shuntaro
Kurushima, Shota
Michitsuji, Toru
Nishihata, Shinya
Okamoto, Momoko
Tsuji, Yoshika
Endo, Yushiro
Shimizu, Toshimasa
Sumiyoshi, Remi
Suzuki, Takahisa
Okada, Akitomo
Koga, Tomohiro
Kawashiri, Shin-ya
Fujikawa, Keita
Igawa, Takashi
Aramaki, Toshiyuki
Ichinose, Kunihiro
Tamai, Mami
Nakamura, Hideki
Mizokami, Akinari
Origuchi, Tomoki
Ueki, Yukitaka
Eguchi, Katsumi
Kawakami, Atsushi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02582-z
- URN
-
urn:nbn:de:101:1-2021102319193893137596
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iwamoto, Naoki
- Sato, Shuntaro
- Kurushima, Shota
- Michitsuji, Toru
- Nishihata, Shinya
- Okamoto, Momoko
- Tsuji, Yoshika
- Endo, Yushiro
- Shimizu, Toshimasa
- Sumiyoshi, Remi
- Suzuki, Takahisa
- Okada, Akitomo
- Koga, Tomohiro
- Kawashiri, Shin-ya
- Fujikawa, Keita
- Igawa, Takashi
- Aramaki, Toshiyuki
- Ichinose, Kunihiro
- Tamai, Mami
- Nakamura, Hideki
- Mizokami, Akinari
- Origuchi, Tomoki
- Ueki, Yukitaka
- Eguchi, Katsumi
- Kawakami, Atsushi
- SpringerLink (Online service)
Other Objects (12)
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
The effect of JAK inhibitors baricitinib and tofacitinib on Th17 cells, regulatory T cells and the Th17/Treg balance in patients with rheumatoid arthritis
Relative Remission and Low Disease Activity Rates of Tofacitinib, Baricitinib, Upadacitinib, and Filgotinib versus Methotrexate in Patients with Disease-Modifying Antirheumatic Drug-Naive Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review
Interaktion der Tyrosinkinase-Inhibitoren Baricitinib und Tofacitinib mit Transportern für organische Kationen
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
The effect of JAK inhibitors baricitinib and tofacitinib on Th17 cells, regulatory T cells and the Th17/Treg balance in patients with rheumatoid arthritis
Relative Remission and Low Disease Activity Rates of Tofacitinib, Baricitinib, Upadacitinib, and Filgotinib versus Methotrexate in Patients with Disease-Modifying Antirheumatic Drug-Naive Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review
Interaktion der Tyrosinkinase-Inhibitoren Baricitinib und Tofacitinib mit Transportern für organische Kationen
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
The effect of JAK inhibitors baricitinib and tofacitinib on Th17 cells, regulatory T cells and the Th17/Treg balance in patients with rheumatoid arthritis
Relative Remission and Low Disease Activity Rates of Tofacitinib, Baricitinib, Upadacitinib, and Filgotinib versus Methotrexate in Patients with Disease-Modifying Antirheumatic Drug-Naive Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review